Literature DB >> 19684520

Left ventricular geometry and endogenous ouabain in a Flemish population.

Tatiana Kuznetsova1, Paolo Manunta, Nunnzia Casamassima, Elisabetta Messaggio, Yu Jin, Lutgarde Thijs, Tom Richart, Robert H Fagard, Giuseppe Bianchi, Jan A Staessen.   

Abstract

BACKGROUND: Endogenous ouabain, an endogenous digitalis-like steroid, is synthesized in the adrenal glands and possibly in the hypothalamus. In vitro and in vivo, endogenous ouabain triggers growth and proliferation of cardiomyocytes.
OBJECTIVE: We therefore investigated the association between left ventricular structure and function and plasma endogenous ouabain in a general population.
METHODS: We randomly recruited 536 individuals from a general population (50.7% women, mean age 53.1 years). Measurements included echocardiographic left ventricular structure and function, blood pressure, plasma endogenous ouabain, and the 24-h urinary excretion of sodium.
RESULTS: The geometric mean plasma endogenous ouabain was 95.5 pmol/l (interquartile range 79.4-120.2 pmol/l). We expressed effect sizes for a 1-SD increase in plasma endogenous ouabain (0.21 on the logarithmic scale), while accounting for important covariables. For a 1-SD increment in plasma endogenous ouabain, SBP, left ventricular posterior wall, the interventricular septum, and relative wall thickness increased by 1.59 mmHg (P = 0.009), 0.138 mm (P = 0.003), 0.152 mm (P = 0.013), and 0.71 x 10 (P = 0.008), respectively. In a sensitivity analysis, involving 431 individuals aged 29-71 years (10-90th percentile interval), a 1-SD increase in plasma endogenous ouabain was associated with opposite trends in ejection fraction (+0.90%, P = 0.005) and left ventricular systolic longitudinal strain (-0.48%, P = 0.011). Moreover, in individuals whose sodium excretion was above median (160 mmol/24 h), the aforementioned associations reached a higher level of statistical significance.
CONCLUSION: Our population-based study suggested that endogenous ouabain might have a trophic effect on the myocardium, independent of blood pressure and other covariables. The clinical implication of these findings remains to be elucidated.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19684520     DOI: 10.1097/HJH.0b013e32832e49a8

Source DB:  PubMed          Journal:  J Hypertens        ISSN: 0263-6352            Impact factor:   4.844


  8 in total

1.  Heritability of left ventricular structure and function in Caucasian families.

Authors:  Yu Jin; Tatiana Kuznetsova; Murielle Bochud; Tom Richart; Lutgarde Thijs; Daniele Cusi; Robert Fagard; Jan A Staessen
Journal:  Eur J Echocardiogr       Date:  2011-03-11

Review 2.  Endogenous ouabain in renal Na(+) handling and related diseases.

Authors:  Paolo Manunta; Elisabetta Messaggio; Nunzia Casamassima; Guido Gatti; Simona Delli Carpini; Laura Zagato; John M Hamlyn
Journal:  Biochim Biophys Acta       Date:  2010-03-11

3.  Mice expressing ouabain-sensitive α1-Na,K-ATPase have increased susceptibility to pressure overload-induced cardiac hypertrophy.

Authors:  Arshani N Wansapura; Valerie M Lasko; Jerry B Lingrel; John N Lorenz
Journal:  Am J Physiol Heart Circ Physiol       Date:  2010-10-15       Impact factor: 4.733

Review 4.  Salt Sensitivity: Challenging and Controversial Phenotype of Primary Hypertension.

Authors:  Rossella Iatrino; Paolo Manunta; Laura Zagato
Journal:  Curr Hypertens Rep       Date:  2016-09       Impact factor: 5.369

5.  Lanosterol Synthase Gene Polymorphisms and Changes in Endogenous Ouabain in the Response to Low Sodium Intake.

Authors:  Chiara Lanzani; Guido Gatti; Lorena Citterio; Elisabetta Messaggio; Simona Delli Carpini; Marco Simonini; Nunzia Casamassima; Laura Zagato; Elena Brioni; John M Hamlyn; Paolo Manunta
Journal:  Hypertension       Date:  2015-12-14       Impact factor: 10.190

6.  Main results of the ouabain and adducin for Specific Intervention on Sodium in Hypertension Trial (OASIS-HT): a randomized placebo-controlled phase-2 dose-finding study of rostafuroxin.

Authors:  Jan A Staessen; Lutgarde Thijs; Katarzyna Stolarz-Skrzypek; Antonella Bacchieri; John Barton; Ezio Degli Espositi; Peter W de Leeuw; Mirosław Dłużniewski; Nicola Glorioso; Andrzej Januszewicz; Paolo Manunta; Viktor Milyagin; Yuri Nikitin; Miroslav Souček; Chiara Lanzani; Lorena Citterio; Mario Timio; Andrzej Tykarski; Patrizia Ferrari; Giovanni Valentini; Kalina Kawecka-Jaszcz; Giuseppe Bianchi
Journal:  Trials       Date:  2011-01-14       Impact factor: 2.279

7.  How full is our antihypertensives pipeline?

Authors:  Dilip Gude
Journal:  J Pharmacol Pharmacother       Date:  2012-01

Review 8.  On the Many Actions of Ouabain: Pro-Cystogenic Effects in Autosomal Dominant Polycystic Kidney Disease.

Authors:  Jessica Venugopal; Gustavo Blanco
Journal:  Molecules       Date:  2017-05-03       Impact factor: 4.411

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.